Cargando…

The epitranscriptome: At the crossroad of cancer prognosis

Detalles Bibliográficos
Autor principal: Di Fazio, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847963/
https://www.ncbi.nlm.nih.gov/pubmed/33517076
http://dx.doi.org/10.1016/j.ebiom.2021.103231
_version_ 1783645025399209984
author Di Fazio, Pietro
author_facet Di Fazio, Pietro
author_sort Di Fazio, Pietro
collection PubMed
description
format Online
Article
Text
id pubmed-7847963
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78479632021-02-04 The epitranscriptome: At the crossroad of cancer prognosis Di Fazio, Pietro EBioMedicine Commentary Elsevier 2021-01-28 /pmc/articles/PMC7847963/ /pubmed/33517076 http://dx.doi.org/10.1016/j.ebiom.2021.103231 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Di Fazio, Pietro
The epitranscriptome: At the crossroad of cancer prognosis
title The epitranscriptome: At the crossroad of cancer prognosis
title_full The epitranscriptome: At the crossroad of cancer prognosis
title_fullStr The epitranscriptome: At the crossroad of cancer prognosis
title_full_unstemmed The epitranscriptome: At the crossroad of cancer prognosis
title_short The epitranscriptome: At the crossroad of cancer prognosis
title_sort epitranscriptome: at the crossroad of cancer prognosis
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847963/
https://www.ncbi.nlm.nih.gov/pubmed/33517076
http://dx.doi.org/10.1016/j.ebiom.2021.103231
work_keys_str_mv AT difaziopietro theepitranscriptomeatthecrossroadofcancerprognosis
AT difaziopietro epitranscriptomeatthecrossroadofcancerprognosis